Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-10 · accession 0001415889-24-023128 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-10 | 2024-09-10 | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale | $12.98 | -684 | 61.9K | -1% | -$8,878 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-10 | S | D | 684 | $12.98 | 61,949 | D | — | — |